AI
IMA

Atom Investors’s ImageneBio Inc IMA Stock Holding History

Atom Investors’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-846
Closed -$14.4K – 566
2024
Q1 		$14.4K Buy
+846
New +$15.4K ﹤0.01% 560

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Atom Investors's IMA Position: Q2 2024 in Review

Atom Investors sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 846 shares — an estimated $14.4K sold.

Atom Investors first reported a position in IMA in Q1 2024 and held it in 1 quarter. The position peaked at $14.4K in Q1 2024. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Atom Investors reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Atom Investors sold 846 ImageneBio Inc shares in Q2 2024, an estimated $14.4K.
  • Atom Investors first reported a position in ImageneBio Inc in Q1 2024 and held it in 1 quarter.
  • Atom Investors's ImageneBio Inc position peaked at $14.4K in Q1 2024.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.